Статья

Smell impairment in COVID-19 patients: Mechanisms and clinical significance

A. Kryukov, A. Kazakova, A. Hecht,
2020

Numerous studies have shown that loss of smell is a serious symptom that requires careful differential diagnosis. There is convinc-ing evidence that a violation of the sense of smell is not so much a sign of the pathology of the nasal cavity and paranasal sinus-es, but it can be a manifestation of neurodegenerative diseases. Some patients with the identified SARS-CoV-2 virus have neurological symptoms. Most of them are not specific-headache, dizziness, fatigue, myalgia. A small percentage of patients with COVID-19 infection have convul-sions, impaired consciousness, and the presence of 2019-NCoV RNA was found in the cerebrospinal fluid. Data on the development of new symptoms of the disease, in the form of anosmia and dysgeusia, are presented.

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2020-01-01

Метаданные

Об авторах
  • A. Kryukov
    Research Clinical Institute of Otorinolaryngology named after. L.I. Sverzhevsky, Pirogov Russian National Research Medical University (RNRMU)
  • A. Kazakova
    Solovyov Moscow Research and Practical Psychoneurological Center
  • A. Hecht
    Solovyov Moscow Research and Practical Psychoneurological Center
Название журнала
  • Vestnik Otorinolaringologii
Том
  • 85
Выпуск
  • 5
Страницы
  • 93-97
Номер гранта
  • undefined
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC BY
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus